X-134473344-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000194.3(HPRT1):c.28-15A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000096 in 937,767 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000097 ( 0 hom. 2 hem. )
Consequence
HPRT1
NM_000194.3 splice_polypyrimidine_tract, intron
NM_000194.3 splice_polypyrimidine_tract, intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.37
Genes affected
HPRT1 (HGNC:5157): (hypoxanthine phosphoribosyltransferase 1) The protein encoded by this gene is a transferase, which catalyzes conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate via transfer of the 5-phosphoribosyl group from 5-phosphoribosyl 1-pyrophosphate. This enzyme plays a central role in the generation of purine nucleotides through the purine salvage pathway. Mutations in this gene result in Lesch-Nyhan syndrome or gout.[provided by RefSeq, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-134473344-A-G is Benign according to our data. Variant chrX-134473344-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2922505.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HPRT1 | NM_000194.3 | c.28-15A>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000298556.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HPRT1 | ENST00000298556.8 | c.28-15A>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000194.3 | P1 | |||
HPRT1 | ENST00000462974.5 | n.186-15A>G | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 3 | |||||
HPRT1 | ENST00000475720.1 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112104Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34266
GnomAD3 genomes
AF:
AC:
1
AN:
112104
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34266
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183048Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67606
GnomAD3 exomes
AF:
AC:
1
AN:
183048
Hom.:
AF XY:
AC XY:
0
AN XY:
67606
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000969 AC: 8AN: 825663Hom.: 0 Cov.: 15 AF XY: 0.00000844 AC XY: 2AN XY: 236879
GnomAD4 exome
AF:
AC:
8
AN:
825663
Hom.:
Cov.:
15
AF XY:
AC XY:
2
AN XY:
236879
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112104Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34266
GnomAD4 genome
AF:
AC:
1
AN:
112104
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34266
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Lesch-Nyhan syndrome;C0268117:Partial hypoxanthine-guanine phosphoribosyltransferase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 28, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at